These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients. Muñoz R; Dominguez A; Muñoz F; Muñoz C; Slako M; Turiel D; Pimentel F; Sharp A; Escalona A Surg Endosc; 2014 Apr; 28(4):1056-62. PubMed ID: 24196558 [TBL] [Abstract][Full Text] [Related]
10. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Escalona A; Pimentel F; Sharp A; Becerra P; Slako M; Turiel D; Muñoz R; Bambs C; Guzmán S; Ibáñez L; Gersin K Ann Surg; 2012 Jun; 255(6):1080-5. PubMed ID: 22534421 [TBL] [Abstract][Full Text] [Related]
11. Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity. Betzel B; Koehestanie P; Aarts EO; Dogan K; Homan J; Janssen IM; Wahab PJ; Groenen MJ; Berends FJ Gastrointest Endosc; 2015 Nov; 82(5):845-52. PubMed ID: 25952090 [TBL] [Abstract][Full Text] [Related]
12. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gersin KS; Rothstein RI; Rosenthal RJ; Stefanidis D; Deal SE; Kuwada TS; Laycock W; Adrales G; Vassiliou M; Szomstein S; Heller S; Joyce AM; Heiss F; Nepomnayshy D Gastrointest Endosc; 2010 May; 71(6):976-82. PubMed ID: 20304396 [TBL] [Abstract][Full Text] [Related]
13. Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes. Colás A; Varela M; Mraz M; Novak D; Cuesta-Frau D; Vigil L; Benes M; Pelikanova T; Haluzik M; Burda V; Vargas B Diabetes Metab Res Rev; 2020 May; 36(4):e3287. PubMed ID: 31916665 [TBL] [Abstract][Full Text] [Related]
14. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. de Moura EG; Martins BC; Lopes GS; Orso IR; de Oliveira SL; Galvão Neto MP; Santo MA; Sakai P; Ramos AC; Garrido Júnior AB; Mancini MC; Halpern A; Cecconello I Diabetes Technol Ther; 2012 Feb; 14(2):183-9. PubMed ID: 21932999 [TBL] [Abstract][Full Text] [Related]
15. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders. Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345 [TBL] [Abstract][Full Text] [Related]
16. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients. Forner PM; Ramacciotti T; Farey JE; Lord RV Obes Surg; 2017 Dec; 27(12):3306-3313. PubMed ID: 29018990 [TBL] [Abstract][Full Text] [Related]
17. Sustained weight loss after duodenal-jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m Boonchaya-Anant P; Bueter M; Gubler C; Gerber PA Clin Obes; 2023 Feb; 13(1):e12561. PubMed ID: 36239531 [TBL] [Abstract][Full Text] [Related]
18. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes. Jirapinyo P; Haas AV; Thompson CC Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867 [TBL] [Abstract][Full Text] [Related]